Literature DB >> 328777

Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation.

A S Fauci, K R Pratt, G Whalen.   

Abstract

In vitro hydrocortisone in physiologic and pharmacologically attainable concentrations caused a marked enhancement of the PWM-induced PFC response of normal human peripheral blood B lymphocytes. This effect was seen only when hydrocortisone was added within the first 24 hr of culture and only when hydrocortisone and PWM were present together in cultures. Only suprapharmacologic concentrations of hydrocortisone (10(-3) M) were capable of suppressing early B cell activation. Late stages of antibody production and secretion were resistant to suppression by even these extraordinarily high concentrations. Hydrocortisone did not replace the T cell requirement of PWM-induced PFC responses. A single dose of in vivo hydrocortisone (400 mg) to normal adult volunteers did not produce this enhancing effect when PFC responses were measured in vitro in the absence of hydrocortisone. The data strongly suggest that the enhancing effect of hydrocortisone was due not to elimination of naturally occurring suppressor cells, but to a modulation of the triggering signal either directly on the B cell itself or via the balance of positive and negative T cell regulation of B cell activation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 328777

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

2.  The effect of cortisol administration on blood plasma immunoglobulin M (IgM) concentrations in masu salmon (Oncorhynchus masou).

Authors:  M Nagae; H Fuda; K Ura; H Kawamura; S Adachi; A Hara; K Yamauchi
Journal:  Fish Physiol Biochem       Date:  1994-05       Impact factor: 2.794

3.  Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

Authors:  I Jokinen; K Poikonen; T Möttönen; P Hannonen; M Oka; J Ilonen; H M Surcel; R Karttunen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

4.  Mechanism of action of glucocorticoid-induced immunoglobulin production: II. Requirement for fetal calf serum.

Authors:  S Sierakowski; J S Goodwin
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

5.  Lenalidomide alone or lenalidomide plus dexamethasone significantly inhibit IgG and IgM in vitro... A possible explanation for their mechanism of action in treating multiple myeloma.

Authors:  E Shannon; F Sandoval; N Greig; P Stagg
Journal:  Int Immunopharmacol       Date:  2012-01-11       Impact factor: 4.932

6.  Activation of human B lymphocytes. VIII. Differential radiosensitivity of subpopulations of lymphoid cells involved in the polyclonally-induced PFC responses of peripheral blood B lymphocytes.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

7.  Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation.

Authors:  T R Cupps; T L Gerrard; R J Falkoff; G Whalen; A S Fauci
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  IgA synthesis by peripheral blood mononuclear cells from normal and selectively IgA deficient subjects.

Authors:  M A King; J V Wells; D S Nelson
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

9.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

10.  Glucocorticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. III. Common variable immunodeficiency.

Authors:  D A Cooper; P Hansen; M Duckett; J B Ziegler; R Penny
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.